CSIMarket
 

Avanos Medical Inc   (AVNS)
Other Ticker:  
 

Avanos Medical Inc 's Working Capital Per Sales

AVNS's Working Capital and Revenue growth



AVNS Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change -18.85 % 14.17 % 20.17 % 2.19 % 11.12 %
Y / Y Revenue Change -34.85 % -15.64 % -16.85 % -2.89 % 12.46 %
Working Capital Per Revenue 0.48 0.45 0.42 0.39 0.38
Total Ranking # 1625 # 2240 # 2290 # 2222 # 2474
Seq. Working Capital Change -27.66 % 1.86 % 17.08 % -5.94 % 1.78 %
Seq. Revenue Change -16.89 % 1.01 % -11.95 % -11.86 % 7.62 %





Comment on AVNS's Working Capital Per Revenue in the fourth quarter 2023
Avanos Medical Inc 's Working Capital Per Revenue sequentially grew to 0.48 during the Q4 2023, below the Avanos Medical Inc average. Due to increase of revenue in the Q4 2023 year on year by -34.85%.

Within Healthcare sector 34 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Avanos Medical Inc Working Capital Per Revenue overall ranking has impoved so far in the Q4 2023 to 1625, from total ranking in the third quarter 2023 at 2240.
Working Capital Per Revenue Ranking
Within: No.
Industry # 6
Sector # 35
S&P 500 # 1625


Working Capital Per Revenue Statistics
High Average Low
4.58
0.6
0.18
(Jun 30 2018)   (Mar 31 2017)



Financial Statements
Avanos Medical Inc 's Working Capital $ 265 Millions Visit AVNS's Balance sheet
Avanos Medical Inc 's Revenues $ 142 Millions Visit AVNS's Income Statement
Where are AVNS's Sales coming from? Visit AVNS's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Intra cellular Therapies Inc   1.28 
Urogen Pharma Ltd   1.27 
Si bone inc   1.24 
Orthopediatrics Corp  1.23 
Olink Holding Ab publ   1.23 
G1 Therapeutics Inc   1.23 
United Therapeutics Corporation  1.20 
Silk Road Medical Inc   1.19 
Biocryst Pharmaceuticals Inc   1.19 
Revance Therapeutics Inc   1.18 
Beigene ltd   1.18 
Axonics Inc   1.17 
Regeneron Pharmaceuticals Inc   1.12 
Fonar Corporation  1.10 
Castle Biosciences Inc   1.10 
Astrazeneca Plc  1.09 
Moderna Inc   1.09 
Glaukos Corp  1.07 
Nuwellis Inc   1.07 
Vertex Pharmaceuticals Inc  1.07 
Alnylam Pharmaceuticals Inc   1.05 
Tela Bio Inc   1.04 
Shockwave Medical Inc   1.03 
Siga Technologies Inc  1.02 
Stereotaxis Inc   0.98 
Caredx Inc   0.98 
Voyager Therapeutics Inc   0.97 
Bio rad Laboratories Inc   0.97 
Amgen Inc   0.92 
Neuronetics inc   0.91 
Date modified: 2024-02-21T20:31:58+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com